PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
CCENT/2010/2 - Medinfar / Activos Grünenthal
Acquired
Assets Grünenthal
Description
a set of tangible and intangible assets necessary for the manufacture, development and marketing of the product Halibut Pomada (an over-the-counter pharmaceutical product) and Halibut Derma products (dermo-cosmetic products).
Acquiring
Laboratório Medinfar - Produtos Farmacêuticos, S.A
Description
a group that produces, markets and promotes medicines intended for the areas of general practice, cardiology, gastroenterology, rheumatology and dermatology; it also has a portfolio of over-the-counter medicines and health products, in particular food supplements, cosmetics and body-care products.
Sector
  • Supply and Food Industry
Activity (NACE)
  • G46 - Wholesale trade (include commission trade), except of motor vehicles and motorcycles
Applicable legislation
Art. 9(1)(a) (Law 18)
Notification thresholds
Market share
Type of merger
Horizontal
Cooperation with sector regulators
Status
Closed
Type of Investigation
Phase 1
AdC’s decision
Case description
Notified on 5 January 2010, this merger operation consists of the acquisition, by Laboratório Medinfar - Produtos Farmacêuticos SA (Medinfar), of exclusive control of a set of assets related to the economic activity of producing, developing, marketing and selling pharmaceutical and dermo-cosmetic products (Target Business), at present controlled by the company Grünenthal SA (Grünenthal).
Timeline
2010-02-11
The Competition Authority Council adopts a decision of non-opposition to merger operation 2/2010 Medinfar / Grünenthal Assets
2010-01-13
Publication of the announcement
Click here to see your activities